Consider the following statements regarding Signet Ring Cell Carcinoma (SRCC):

1. SRCC is a rare and aggressive subtype of colorectal cancer, characterized by cells that appear like signet rings under a microscope due to mucus pushing the nucleus to one side.

2. Patient-Derived Organoids (PDOs) and Patient-Derived Xenografts (PDXs) are novel methods developed to study SRCC, where PDOs are miniature 3D tumour models grown in lab dishes, and PDXs involve implanting human tumour cells into mice.

Which of the statements given above is/are correct?